Brentuximab vedotin

About

Therapy type: Targeted therapy

Therapy strategy: target CD30 antigens

Mappings

NCI Thesaurus: Brentuximab Vedotin (coding:ncit:C66944)

RxNorm: brentuximab vedotin (coding:rxcui:1147320, coding:omop:37017170)

SNOMED: Brentuximab vedotin (coding:sctid:713395006, coding:omop:40241969)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations Biomarkers Cancer types Therapies
FDA (1) CD30 + Anaplastic Large Cell Lymphoma Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone
FDA (1) CD30 + Anaplastic Large Cell Lymphoma Brentuximab vedotin
EMA (1) CD30 + Hodgkin Lymphoma Brentuximab vedotin, Dacarbazine, Doxorubicin, Vinblastine
EMA (2) CD30 + Hodgkin Lymphoma Brentuximab vedotin
EMA (1) CD30 + Cutaneous T-cell Lymphoma Brentuximab vedotin
EMA (1) CD30 + Hodgkin Lymphoma Brentuximab vedotin, Cyclophosphamide, Dacarbazine, Dexamethasone, Doxorubicin, Etoposide